SCON Superconductor Technologies Inc

On March 3, 2014, David Vellequette resigned from the board of directors (the "Board") of Superconductor Technologies Inc. (the "Company"). Consistent with past practice, effective as of his date of termination of board service, the Company also extended the exercise period of options held by Mr. Vellequette to the term of the options and accelerated the vesting of previously granted restricted stock.

Election of Dan L. Halvorson

On March 3, 2014, the Board elected Dan L. Halvorson, 48, to the Board, filling the vacancy created by the resignation of Mr. Vellequette. Mr. Halvorson will serve as the Class 3 director for a term ending as of the annual meeting of stockholders in 2016. He was appointed to and will chair the Audit Committee, and was also appointed to the Governance and Nominating Committee and the Compensation Committee of the Company. Mr. Halvorson is our "audit committee financial expert", as defined by the SEC under Item 407(d)(5)(ii) and (iii) of Regulation S-K, and "financially sophisticated" within the meaning of Nasdaq Marketplace Rule 5605(c)(2)(A). There are no arrangements or understandings by which Mr. Halvorson was named a director. Neither the Company nor any of its subsidiaries was involved in any transactions with Mr. Halvorson or his immediate family that are reportable pursuant to Section 404(a) of Regulation S-K.

Mr. Halvorson is currently the Executive Vice President and Chief Financial Officer for OneRoof Energy, Inc., a technology finance provider for residential solar systems. Mr. Halvorson previously served as the Executive Vice President and Chief Financial Officer of Mandalay Digital Group, Inc. (NASDAQ: MNDL) from September 2012 through December 2012, Executive Vice President-Operations and Chief Financial Officer for DivX, Inc. (NASDAQ: DIVX) from 2007 until its acquisition by Sonic Solutions in October 2010. Prior to joining DivX, he served at Novatel Wireless, Inc., from 2000 to 2007 (NASDAQ: NVTL), most recently as its Chief Financial Officer. He was Director of Finance for Dura Pharmaceuticals, Inc. from 1988 to 2000, when the company was acquired by Elan Corporation, and Director of Finance for Alliance Pharmaceutical Corp. from 1996 to 1998.

From 1988 to 1994, Mr. Halvorson was with Deloitte & Touche LLC, and subsequently, with PriceWaterhouseCoopers LLP from 1994 until he joined Alliance Pharmaceutical Corp. in 1996.

Mr. Halvorson is a member of the American Institute of Certified Public Accountants, California Society of Certified Public Accountants, and the Corporate Directors Forum. Mr. Halvorson is a certified public accountant (inactive) and holds a Bachelor of Science in Business Administration and Accounting from San Diego State University.

Concurrent with his appointment to the Board, Mr. Halvorson was granted 25,000 shares of restricted common stock. He is eligible to participate in all compensation plans available to the Company's other directors, as described in the Company's most recently filed proxy statement.